Among the drugs targeting microtubule functions by interfering with tubulin subunits, epothilones represent a class of anticancer agents which recently entered clinical development. Although epothilones share mechanisms of action similar to taxanes, they have non-overlapping mechanisms of resistance; in particular, while overexpression of class III β-tubulin plays a major role in taxane resistance, epothilones display their highest efficacy in class III β-tubulin overexpressing malignancies. Three compounds belonging to this family (patupilone, ixabepilone and sagopilone), have been actively investigated in clinical trials, and some of them are at an advanced stage of development. This review provides a comprehensive analysis of the available literature on epothilones, focusing on their clinical development and potential as an additional weapon in the arsenal against tumors.

Ferrandina, M. G., Mariani, M., Andreoli, M., Shahabi, S., Scambia, G., Ferlini, C., Novel Drugs Targeting Microtubules: the Role of Epothilones, <<CURRENT PHARMACEUTICAL DESIGN>>, 2012; 18 (19): 2793-2803 [http://hdl.handle.net/10807/39938]

Novel Drugs Targeting Microtubules: the Role of Epothilones

Ferrandina, Maria Gabriella;Mariani, Marisa;Andreoli, Mirko;Scambia, Giovanni;Ferlini, Cristiano
2012

Abstract

Among the drugs targeting microtubule functions by interfering with tubulin subunits, epothilones represent a class of anticancer agents which recently entered clinical development. Although epothilones share mechanisms of action similar to taxanes, they have non-overlapping mechanisms of resistance; in particular, while overexpression of class III β-tubulin plays a major role in taxane resistance, epothilones display their highest efficacy in class III β-tubulin overexpressing malignancies. Three compounds belonging to this family (patupilone, ixabepilone and sagopilone), have been actively investigated in clinical trials, and some of them are at an advanced stage of development. This review provides a comprehensive analysis of the available literature on epothilones, focusing on their clinical development and potential as an additional weapon in the arsenal against tumors.
eng
Ferrandina, M. G., Mariani, M., Andreoli, M., Shahabi, S., Scambia, G., Ferlini, C., Novel Drugs Targeting Microtubules: the Role of Epothilones, <>, 2012; 18 (19): 2793-2803 [http://hdl.handle.net/10807/39938]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/39938
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 28
social impact